Auro Vaccines Llc
CAGE Code: 8EWB4
NCAGE Code: 8EWB4
Status: Active
Type: Commercial Supplier
Summary
Auro Vaccines Llc is an Active Commercial Supplier with the Cage Code 8EWB4.
Address
401 N Middletown Rd Bldg 205F
Pearl River NY 10965-1298
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Dames And Moore Inc Charlie's Skid Steer And Maintenance Zeltine Co Inc Parthenon Publishing Group Sys-Con La Installers Llc Dream Design Construct Corp Strohmeyers Services Inc Rogers Consumer Products, Inc. Griffin Crane And Steel Service, Inc Hudson Technologies, Inc. Diagnostic Systems Services Inc Inland Motor Corp Cleveland Folding Machine Co Cheslers Stationary Shah Consultants Tom Cresson Electric Llc Three Deuces Inc. Premier Professional Consulants, Llc Frontline Communications Corporation
Frequently Asked Questions (FAQ) for CAGE 8EWB4
- What is CAGE Code 8EWB4?
- 8EWB4 is the unique identifier used by NATO Organizations to reference the physical entity known as Auro Vaccines Llc located at 401 N Middletown Rd Bldg 205F, Pearl River NY 10965-1298, United States.
- Who is CAGE Code 8EWB4?
- 8EWB4 refers to Auro Vaccines Llc located at 401 N Middletown Rd Bldg 205F, Pearl River NY 10965-1298, United States.
- Where is CAGE Code 8EWB4 Located?
- CAGE Code 8EWB4 is located in Pearl River, NY, USA.
Contracting History for CAGE 8EWB4 Most Recent 25 Records
- 75N93020C00040
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- 22 Sep 2022
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,920,669.81
- Department Of Health And Human Services (Hhs)
- 75N93020C00040
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- 31 Aug 2023
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $10,016,090.55
- Department Of Health And Human Services (Hhs)
- 75N93020C00040
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- 12 Jun 2023
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $8,268,021.55
- Department Of Health And Human Services (Hhs)
- 75N93020C00040
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- 14 Mar 2023
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,920,669.81
- Department Of Health And Human Services (Hhs)
- 75N93020C00040
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- 29 Jun 2022
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,935,263.81
- Department Of Health And Human Services (Hhs)
- 75N93020C00040
- Eo14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- 2 Nov 2021
- Eo14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,941,676.80
- Department Of Health And Human Services (Hhs)
- 75N93020C00040
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- 1 Apr 2022
- Eo 14042 Advanced Development Of Multivalent Vaccine Candidates For Filovirus And Lassa Fever
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,941,676.80
- Department Of Health And Human Services (Hhs)